October 22, 2019 / 6:14 AM / a month ago

BRIEF-UK competition watchdog launches Roche-Spark inquiry

Oct 22 (Reuters) - Spark Therapeutics Inc:

* UK'S CMA - CONSIDERING WHETHER ROCHE-SPARK DEAL MAY RESULT IN LESSENING OF COMPETITION WITHIN ANY MARKET OR MARKETS IN UK FOR GOODS OR SERVICES

* UK'S COMPETITION AND MARKETS AUTHORITY SAYS CONSIDERING WHETHER IT IS OR MAY BE CASE THAT MERGER OF ROCHE HOLDING AND SPARK THERAPEUTICS WILL RESULT IN CREATION OF A RELEVANT MERGER SITUATION UNDER MERGER PROVISIONS OF ENTERPRISE ACT 2002

* UK'S COMPETITION AND MARKETS AUTHORITY ANNOUNCES LAUNCH OF ITS MERGER INQUIRY BY NOTICE TO PARTIES ON 21 OCTOBER 2019 AND HAS A DEADLINE OF 16 DECEMBER 2019 FOR ITS PHASE 1 DECISION. Source text for Eikon: Further company coverage: (Reporting By Sinead Cruise)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below